Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?

Tumori

Volumn 94, Issue 3, 2008, Pages 327-332

  Kim, Hak Jae ^a   Kim, Suzy ^b   Ha, Sung Whan ^a   Wu, Hong Gyun ^a,b  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Late complication; Radio therapy; Uterine cervix cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CLINICAL EVALUATION; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; RADIATION DOSE; RADIATION RESPONSE; RECTUM CANCER; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

EID: 48249136167     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400307     Document Type: Article

References (23)

1. Pedersen D, Bentzen SM, Overgaard J: Early and late radio-therapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 29: 941-952, 1994.
2. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Aackl A: Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol, 42: 143-153, 1997.
3. Huang EY, Wang CJ, Hsu HC, Hao L, Chen HC, Sun LM: Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose. Gynecol Oncol, 95: 101-108, 2004.
4. Roeske JC, Mundt AJ, Halpern H, Sweeney P, Sutton H, Powers C, Rotmensch J, Waggoner S, Weichselbaum RR: Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys, 37: 351-358, 1997.
5. Chun M, Kang S, Kil HJ: Rectal bleeding and its management after irradiation for cervix cancer. J Korean Soc Ther Radiol Oncol, 20: 343-352, 2002.
6. ICRU Report 38: Dose and volume speciflcation for reporting intracavitary therapy in gynecology. International Commission on Radiation Units and Measurements, Bethesda, Maryland, 1985.
7. Hille A, Christiansen H, Pradier O, Hermann RM, Siekmeyer B, Weiss E, Hilgers R, Hess CF, Schmidberger H: Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol, 181: 606-614, 2002.
8. Miller AR, Martenson JA, Nelson H, Schleck CD, Ilstrup DM, Gunderson LL, Donohue JH: The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys, 43: 817-825, 1999.
9. Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K: High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience. Cancer, 69: 175-180, 1992.
10. Ha SW, ChungWK, Kim JH: The relationship between radiation dose and late complication of bladder in carcinoma of the uterine cervix. J Korean Soc Thera Radio Oncol, 11: 377-385, 1993.
11. Perez CA, Breaux S, Bedwinek JM, Madoc-Jones H, Camel HM, Purdy JA, Walz BJ: Radiation therapy alone in treatment of carcinoma of the uterine cervix. Cancer, 54: 235-246, 1984.
12. Clark BG, Souhami L, Roman TN, Evans MD, Pla C: Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis. Int J Radiat Oncol Biol Phys, 28: 1243-1250, 1994.
13. Pourquier H, Dubois JB, Delard R: Cancer of the uterine cervix; Dosimetric guidelines for prevention of late rectal and rectosignoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys, 8: 1887-1895, 1982.
14. Stryker JA, Bartholomew M, Velkley DE, Cunningham DE, Mortel R, Craycraft G, Shafer J: Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol, 29: 1-11, 1988.
15. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, Salvajoly JV: High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys, 50: 1123-1135, 2001.
16. Takeshi K, Katsuyuki K, Yoshiaki T, Teppei S, Tadayoshi M, Akira M, Katsumi M: Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys, 41: 319-327, 1998.
17. Kim TH, Choi J, Park SY, Lee SH, Lee KC, Yang DS, Shin KH, Cho KH, Lim HS, Kim JY: Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer, 104: 1304-1311, 2005.
18. Kim WD, Park WY: Rectal complication followlng radical radiotherapy in carcinoma of the cervix. J Korean Soc Thera Radio Oncol, 24: 44-50, 2006.
19. Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R: Fractionation in medium dose rate brachytherapy of cancer of the cervix. Int J Radiat Oncol Biol Phys, 35: 907-914, 1996.
20. Rodrigus P, De Winter K, Venselaar JL, Leers WH: Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol, 42: 137-141, 1997.
21. Newman G: Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix. Radiother Oncol, 39: 97-103, 1996.
22. Horiot JC, Pigneux J, Pourpuier H, Schraub S, Achielle E, Keiling R, Combes P, Rozan R, Vrousos C, Daly N: Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys, 14: 605-611, 1998.
23. Van Lancker M, Storme G. Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications. Int J Radiat Oncol Biol Phys, 20: 1125-1129, 1991.